/ Print /

Benefit design and pricing

Insulin treatment persistence varies among payersA study from Walgreens provides a benchmark of basal insulin treatment persistence across different payers in the United States.
More resources needed for medication-assisted treatmentInclude medication-assisted treatment high on the list of clinical tools used to treat opioid addiction.
Genetic testing: Two downsides to considerGenetic testing holds great promise, but there are some critical drawbacks to consider.
Express Scripts’ 2016 Drug Trend Report: 7 things to knowReport highlights spending trends in key areas, including specialty medications, oncology, diabetes, and inflammatory conditions.
Why ACA works better for consumers buying on their ownCommonwealth Fund’s 2016 Biennial Health Insurance Survey found significant improvements in people’s ability to buy health plans on their own after implementation of the ACA insurance reforms.
Survey: Healthcare price transparency tools underutilizedManaged Healthcare Executive’s 2017 Technology Survey findings reveal that tools to help consumers estimate the cost of healthcare may be underutilized. Here’s what UnitedHealthcare is doing about that.
ACOs support programs that increase value in pediatricsStudy: ACOs can be part of the structure to improve outcomes in children with medical complexity.
What billions in lost pharma revenue means for managed carePharmaceutical manufacturer relationships and next-gen value based contracts are primed to accelerate value-derivation from your drug spend.
Integrating pharmacy benefit, medical benefit cuts costsHere’s how one non-profit health plan harnessed the power of medical and pharmacy data to rein in drug costs.
Three ways technology can lead to bundled payment successLay the groundwork for bundled payment; here are three areas in which technology can play a role.